Início › Câncer Colorretal › Virgínia › Arlington
Ensaios clínicos de Câncer Colorretal em Arlington, VA
52 estudos para Câncer Colorretal estão buscando participantes em locais em Arlington e arredores (num raio de aproximadamente 30 milhas). Abra um estudo para ver quem pode participar e como contatar a equipe.
Texto oficial do estudo (Inglês)
Recrutando participantes para um estudo? Destaque-o no topo desta página — $99 por 30 dias →
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
RecrutandoFase 1
- NEXT Oncology Virginia, Fairfax · a 11 mi de distância
The Vanguard Study: Testing a New Way to Screen for Cancer
RecrutandoVoluntários saudáveis bem-vindos
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
- Inova Fair Oaks Hospital, Fairfax · a 11 mi de distância
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
RecrutandoFase 2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
- NEXT Virginia, Fairfax · a 11 mi de distância
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
RecrutandoFase 1/2
- Inova Schar Cancer Institute, Fairfax · a 11 mi de distância
- Virginia Cancer Specialists, PC, Fairfax · a 11 mi de distância
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
RecrutandoFase 1
- ALX Center 2, Fairfax · a 11 mi de distância
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RecrutandoFase 3
- Virginia Cancer Specialists, PC, Arlington
- Virginia Cancer Specialists, PC, Fairfax · a 11 mi de distância
- Virginia Cancer Specialists, PC, Reston · a 14 mi de distância
- e mais 1
Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or Targeted Therapy and/or ICI, for the Treatment of Patients With Advanced Gastrointestinal Cancers, Including Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study)
RecrutandoFase 1/2
- NEXT Oncology, Fairfax · a 11 mi de distância
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
RecrutandoFase 2
- Virginia Cancer Specialists - Fairfax /ID# 271351, Fairfax · a 11 mi de distância
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
RecrutandoFase 3
- Virginia Cancer Specialists, Arlington
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
RecrutandoFase 3
- Virginia Cancer Specialists, Arlington
- Inova Schar Cancer Institute Dept of Fairfax Hospital, Fairfax · a 11 mi de distância
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
RecrutandoFase 2/3
- Local Institution - 0278, Fairfax · a 11 mi de distância
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RecrutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · a 11 mi de distância
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
RecrutandoFase 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · a 11 mi de distância
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
RecrutandoFase 1
- NEXT - Virginia, Fairfax · a 11 mi de distância
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
RecrutandoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
RecrutandoFase 1
- NEXT Oncology, Fairfax · a 11 mi de distância
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
RecrutandoFase 3
- Clinical Study Site, Fairfax · a 11 mi de distância
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer
RecrutandoFase 2
- Inova Schar Cancer, Fairfax · a 11 mi de distância
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
RecrutandoFase 1
- NEXT Oncology, Fairfax · a 11 mi de distância
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RecrutandoFase 1/2
- Clinical Trial Site, Fairfax · a 11 mi de distância
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
RecrutandoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors
RecrutandoFase 1
- Next Virginia, Fairfax · a 11 mi de distância
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
RecrutandoFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RecrutandoFase 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 274586, Fairfax · a 11 mi de distância
- Virginia Cancer Specialists - Fairfax /ID# 274339, Fairfax · a 11 mi de distância
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
RecrutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · a 11 mi de distância
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RecrutandoFase 1
- NEXT Texas LLC - Virginia, Fairfax · a 11 mi de distância
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
RecrutandoFase 1
- Research Site, Fairfax · a 11 mi de distância
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
RecrutandoFase 1
- NEXT Oncology Virginia, Fairfax · a 11 mi de distância
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
RecrutandoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RecrutandoFase 1
- NEXT Oncology Virginia, Fairfax · a 11 mi de distância
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
RecrutandoFase 1/2
- Next Oncology Virginia, Fairfax · a 11 mi de distância
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
RecrutandoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi de distância
A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
RecrutandoFase 1
- NEXT Virginia, LLC, Fairfax · a 11 mi de distância
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
RecrutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RecrutandoFase 1/2
- NEXT Virginia, Fairfax · a 11 mi de distância
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RecrutandoFase 1/2
- NEXT, Virginia, Fairfax · a 11 mi de distância
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
RecrutandoFase 1
- NEXT Virginia, Fairfax · a 11 mi de distância
Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
RecrutandoFase 1
- Virginia Cancer Specialists, Fairfax · a 11 mi de distância
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
RecrutandoFase 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · a 11 mi de distância
Ensaios de Câncer Colorretal em outras cidades
- Houston, TX102 estudos
- New York City, NY78 estudos
- Nashville, TN69 estudos
- Boston, MA63 estudos
- Los Angeles, CA59 estudos
- St. Louis, MO50 estudos
- San Antonio, TX46 estudos
- Philadelphia, PA44 estudos
- Grand Rapids, MI40 estudos
- Baldwin Park, CA37 estudos
- Chicago, IL34 estudos
- Tampa, FL34 estudos
Outros estudos em Arlington
- Câncer de Pulmão de Não Pequenas Células104 estudos
- Câncer Metastático53 estudos
- Câncer (todos os tipos)48 estudos
- Câncer de Mama47 estudos
- Câncer de Ovário46 estudos
- Câncer de Pulmão41 estudos
- Câncer Endometrial39 estudos
- Câncer de Pâncreas33 estudos
- Carcinoma de Células Escamosas de Cabeça e Pescoço26 estudos
- Câncer de Pulmão de Células Pequenas23 estudos
- Câncer de Estômago20 estudos
- Câncer de Mama Triplo-Negativo20 estudos
Fonte: ClinicalTrials.gov, dados obtidos em 6 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.